Literature DB >> 24343861

IRES mediated translational regulation of p53 isoforms.

Arandkar Sharathchandra1, Aanchal Katoch, Saumitra Das.   

Abstract

p53 is a well known tumor suppressor protein that plays a critical role in cell cycle arrest and apoptosis. It has several isoforms which are produced by transcriptional and posttranscriptional regulatory mechanisms. p53 mRNA has been demonstrated to be translated into two isoforms, full-length p53 (FL-p53) and a truncated isoform ΔN-p53 by the use of alternative translation initiation sites. The mechanism of translation regulation of these two isoforms was further elucidated by the discovery of IRES elements in the p53 mRNA. These two IRESs were shown to regulate the translation of p53 and ΔN-p53 in a distinct cell-cycle phase-dependent manner. This review focuses on the current understanding of the regulation of p53 IRES mediated translation and the role of cis and trans acting factors that influence expression of p53 isoforms.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24343861     DOI: 10.1002/wrna.1202

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  19 in total

Review 1.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

2.  Nonsense mutation-dependent reinitiation of translation in mammalian cells.

Authors:  Sarit Cohen; Lior Kramarski; Shahar Levi; Noa Deshe; Oshrit Ben David; Eyal Arbely
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

3.  Influence of metabolic stress on translation of p53 isoforms.

Authors:  Debjit Khan; Samit Chattopadhyay; Saumitra Das
Journal:  Mol Cell Oncol       Date:  2015-05-05

4.  Cancer-specific mutations in p53 induce the translation of Δ160p53 promoting tumorigenesis.

Authors:  Marco M Candeias; Masatoshi Hagiwara; Michiyuki Matsuda
Journal:  EMBO Rep       Date:  2016-10-04       Impact factor: 8.807

5.  5'-UTR recruitment of the translation initiation factor eIF4GI or DAP5 drives cap-independent translation of a subset of human mRNAs.

Authors:  Solomon A Haizel; Usha Bhardwaj; Ruben L Gonzalez; Somdeb Mitra; Dixie J Goss
Journal:  J Biol Chem       Date:  2020-06-22       Impact factor: 5.157

Review 6.  p53 Isoforms as Cancer Biomarkers and Therapeutic Targets.

Authors:  Liuqun Zhao; Suparna Sanyal
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

7.  Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.

Authors:  Luiza Steffens Reinhardt; Kira Groen; Brianna C Morten; Jean-Christophe Bourdon; Kelly A Avery-Kiejda
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

8.  An internal ribosome entry site in the coding region of tyrosyl-DNA phosphodiesterase 2 drives alternative translation start.

Authors:  Annie C Chou; Aaron Aslanian; Huaiyu Sun; Tony Hunter
Journal:  J Biol Chem       Date:  2018-12-28       Impact factor: 5.157

Review 9.  A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation.

Authors:  Marina Kazantseva; Sunali Mehta; Ramona A Eiholzer; Noelyn Hung; Anna Wiles; Tania L Slatter; Antony W Braithwaite
Journal:  Mamm Genome       Date:  2018-07-10       Impact factor: 2.957

Review 10.  Translation acrobatics: how cancer cells exploit alternate modes of translational initiation.

Authors:  Ashwin Sriram; Jonathan Bohlen; Aurelio A Teleman
Journal:  EMBO Rep       Date:  2018-09-17       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.